Katherine Donegan

1.6k total citations · 1 hit paper
20 papers, 1.1k citations indexed

About

Katherine Donegan is a scholar working on Epidemiology, Infectious Diseases and Health. According to data from OpenAlex, Katherine Donegan has authored 20 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 6 papers in Infectious Diseases and 4 papers in Health. Recurrent topics in Katherine Donegan's work include HIV/AIDS drug development and treatment (4 papers), Vaccine Coverage and Hesitancy (4 papers) and Influenza Virus Research Studies (3 papers). Katherine Donegan is often cited by papers focused on HIV/AIDS drug development and treatment (4 papers), Vaccine Coverage and Hesitancy (4 papers) and Influenza Virus Research Studies (3 papers). Katherine Donegan collaborates with scholars based in United Kingdom, Netherlands and United States. Katherine Donegan's co-authors include B. King, P J Bryan, Elizabeth Miller, Edna Kara, Helen Campbell, Mary Ramsay, Sonia Ribeiro, Gayatri Amirthalingam, Norman K. Fry and Nick Andrews and has published in prestigious journals such as The Lancet, BMJ and SLEEP.

In The Last Decade

Katherine Donegan

18 papers receiving 1.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effectiveness of maternal pertussis vaccination in England: an observational study

2014 529 citations Gayatri Amirthalingam, Nick Andrews et al. The Lancet profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Katherine Donegan	709	543	406	152	90	20	1.1k
Patti Benson	966 1.4×	247 0.5×	369 0.9×	288 1.9×	71 0.8×	11	1.5k
Noelle M. Cocoros	488 0.7×	125 0.2×	95 0.2×	205 1.3×	37 0.4×	76	1.1k
Helen Kalies	306 0.4×	200 0.4×	127 0.3×	61 0.4×	34 0.4×	29	706
Alison Tse Kawai	278 0.4×	50 0.1×	156 0.4×	126 0.8×	34 0.4×	31	839
Rebecca V. Fink	498 0.7×	107 0.2×	437 1.1×	107 0.7×	8 0.1×	22	656
L Pelletier	494 0.7×	71 0.1×	127 0.3×	93 0.6×	24 0.3×	27	980
Ruth Blackburn	443 0.6×	91 0.2×	70 0.2×	196 1.3×	86 1.0×	59	1.0k
Robert T. Chen	559 0.8×	84 0.2×	381 0.9×	235 1.5×	14 0.2×	8	884
Anne K. Örtqvist	359 0.5×	49 0.1×	65 0.2×	125 0.8×	22 0.2×	48	1.2k
Jennifer E. Isenor	415 0.6×	29 0.1×	453 1.1×	226 1.5×	14 0.2×	61	906

Countries citing papers authored by Katherine Donegan

Since Specialization

Citations

This map shows the geographic impact of Katherine Donegan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine Donegan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine Donegan more than expected).

Fields of papers citing papers by Katherine Donegan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine Donegan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine Donegan. The network helps show where Katherine Donegan may publish in the future.

Co-authorship network of co-authors of Katherine Donegan

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine Donegan. A scholar is included among the top collaborators of Katherine Donegan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine Donegan. Katherine Donegan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wong, Jenny, et al.. (2025). Implementation and Results of Active Vaccine Safety Monitoring During the COVID-19 Pandemic in the UK: A Regulatory Perspective. Drug Safety. 48(12). 1365–1385.

Booth, Helen, John Connelly, Daniel Dedman, Katherine Donegan, & Alison Cave. (2025). A Regulatory Perspective on a UK Federated Data Network for Medicines and Medical Devices: Lessons from a ‘Study-A-Thon’. Therapeutic Innovation & Regulatory Science. 60(1). 1–7.

Tazare, John, Shirley Wang, Rosa Gini, et al.. (2024). Sharing Is Caring? International Society for Pharmacoepidemiology Review and Recommendations for Sharing Programming Code. Pharmacoepidemiology and Drug Safety. 33(9). e5856–e5856. 2 indexed citations

Hedenmalm, Karin, Kevin Blake, Katherine Donegan, et al.. (2019). A European multicentre drug utilisation study of the impact of regulatory measures on prescribing of codeine for pain in children. Pharmacoepidemiology and Drug Safety. 28(8). 1086–1096. 14 indexed citations

Ghosh, Rebecca, et al.. (2019). How Clinical Practice Research Datalink data are used to support pharmacovigilance. Therapeutic Advances in Drug Safety. 10. 584395962–584395962. 28 indexed citations

Donegan, Katherine, et al.. (2018). Exploring the Potential Routine Use of Electronic Healthcare Record Data to Strengthen Early Signal Assessment in UK Medicines Regulation: Proof-of-Concept Study. Drug Safety. 41(9). 899–910. 4 indexed citations

Seabroke, Suzie, Jenny Wong, Katherine Donegan, et al.. (2018). Safety of multicomponent meningococcal group B vaccine (4CMenB) in routine infant immunisation in the UK: a prospective surveillance study. The Lancet Child & Adolescent Health. 2(6). 395–403. 46 indexed citations

Bollaerts, Kaatje, Tom De Smedt, Katherine Donegan, Lina Titievsky, & Vincent Bauchau. (2018). Benefit–Risk Monitoring of Vaccines Using an Interactive Dashboard: A Methodological Proposal from the ADVANCE Project. Drug Safety. 41(8). 775–786. 12 indexed citations

Donegan, Katherine, Nick C. Fox, Nick Black, et al.. (2017). Trends in diagnosis and treatment for people with dementia in the UK from 2005 to 2015: a longitudinal retrospective cohort study. The Lancet Public Health. 2(3). e149–e156. 102 indexed citations

10.

Donegan, Katherine, et al.. (2017). The impact of regulatory action on the co‐prescribing of renin–angiotensin system blockers in UK primary care. Pharmacoepidemiology and Drug Safety. 26(7). 858–862. 9 indexed citations

11.

Stowe, Julia, Christopher Kosky, Gary Dennis, et al.. (2016). Risk of Narcolepsy after AS03 Adjuvanted Pandemic A/H1N1 2009 Influenza Vaccine in Adults: A Case-Coverage Study in England. SLEEP. 39(5). 1051–1057. 38 indexed citations

12.

Thomson, A. G., et al.. (2016). Patterns of anti-diabetic medication use in patients with type 2 diabetes mellitus in England and Wales. Pharmacoepidemiology and Drug Safety. 26(2). 127–135. 16 indexed citations

13.

Donegan, Katherine, B. King, & P J Bryan. (2014). Safety of pertussis vaccination in pregnant women in UK: observational study. BMJ. 349(jul11 1). g4219–g4219. 202 indexed citations

14.

Payne, Helen, Ali Judd, Katherine Donegan, et al.. (2014). Incidence of Pneumococcal and Varicella Disease in HIV-infected Children and Adolescents in the United Kingdom and Ireland, 1996–2011. The Pediatric Infectious Disease Journal. 34(2). 149–154. 4 indexed citations

15.

Amirthalingam, Gayatri, Nick Andrews, Helen Campbell, et al.. (2014). Effectiveness of maternal pertussis vaccination in England: an observational study. The Lancet. 384(9953). 1521–1528. 529 indexed citations breakdown →

16.

Donegan, Katherine, et al.. (2013). Bivalent human papillomavirus vaccine and the risk of fatigue syndromes in girls in the UK. Vaccine. 31(43). 4961–4967. 51 indexed citations

17.

Donegan, Katherine, Katja Doerholt, Ali Judd, et al.. (2012). Lopinavir Dosing in HIV-infected Children in the United Kingdom and Ireland. The Pediatric Infectious Disease Journal. 32(1). 45–50. 12 indexed citations

18.

Mugisha, Joseph, Katherine Donegan, Sarah Fidler, et al.. (2012). Mean Corpuscular Volume as a Marker for Adherence to Zidovudine-Containing Therapy in HIV-Infected Adults. The Open AIDS Journal. 6(1). 45–52. 4 indexed citations

19.

Donegan, Katherine, A Sarah Walker, David Dunn, et al.. (2012). The Prevalence of Darunavir-Associated Mutations in HIV-1-Infected Children in the Uk. Antiviral Therapy. 17(4). 599–603. 1 indexed citations

20.

Donegan, Katherine, A Sarah Walker, David Dunn, et al.. (2011). The Prevalence of Darunavir-Associated Mutations in HIV-1-Infected Children in the Uk. Antiviral Therapy. 17(4). 599–603. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact